Condition: Autoimmune Hepatitis · Primary Sclerosing Cholangitis · Non-Alcoholic Fatty Liver Disease · Sponsor: Chungnam National University Hospital
In this study, we aim to identify gut microbiomes specific to patients with chronic refractory liver disease and to conduct a gut-liver axis study on the pathogenesis and disease progression.
This description comes directly from the study's public registry record.
Soon Ok Kim · 82-42-280-6717 · dona3734@cnuh.co.kr
Hyuksoo Eun · 82-42-280-7418 · hyuksoo@cnuh.co.kr
Always discuss trial participation with your own doctor first.
| Chungnam National University Hospita | Daejeon, Jung-gu, South Korea | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06519162